Plus   Neg

After Market Hours: Synaptics, GenMark, TechnipFMC Gains; MOGU, Hepion Slips

Synaptics Inc. (SYNA) - The company gained nearly 5% in extended trading session Tuesday after it said it agreed to buy certain assets and manufacturing rights associated with the wireless IoT business of Broadcom (AVGO) for about $250 million in an all-cash transaction.

GenMark Diagnostics, Inc. (GNMK) - The molecular diagnostics company jumped over 5% on Tuesday after-hours. GenMark said it expects second-quarter revenues to be about $40.1 million, representing an increase of 118% from last year. Analysts polled by Thomson Reuters currently estimate revenues of $31.39 million.

TechnipFMC plc (FTI) - The oil and gas company gained nearly 10% in after-hours Tuesday after it signed a major Engineering, Procurement, and Construction (EPC) contract with Assiut National Oil Processing Company for the construction of a new Hydrocracking Complex for the Assiut refinery in Egypt.

MOGU Inc. (MOGU) - Shares of the Chinese online fashion company tanked 10% in after-hours trading after the company's stock more than doubled in regular trading on Tuesday.

Hepion Pharmaceuticals, Inc. (HEPA) - Shares of the biopharmaceutical company slipped over 7% after the bell on Tuesday, despite gaining 43% in regular trade. The company had announced that its anti-fibrotic drug candidate was efficacious in two pre-clinical research related to COVID-19.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Workplace technology company Xerox Holdings Corp. (XRX) reported Tuesday that net income for the third quarter declined to $90 million or $0.41 per share from $221 million or $0.68 per share in the year-ago quarter. Excluding items, adjusted earnings for the quarter were $0.48 per share, compared... While reporting financial results for the third quarter on Tuesday, Pfizer Inc. (PFE) tightened its full-year 2020 guidance range for adjusted earnings and revenues. However, the company reaffirmed all 2020 financial guidance components for New Pfizer and Upjohn. For fiscal 2019, the company now projects... Eli Lilly and Company (LLY) said it delivered solid financial results in the third quarter, as the company's key growth products continued to be the catalyst for volume-based revenue growth. On a non-GAAP basis, earnings per share increased 4 percent. Revenue rose 5 percent driven by volume growth of...
Follow RTT